ResearcherNingxia Medical University General HospitalNo recent work listed

Peng Yuan

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper

Papers 1

miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1. Co-author DOI 10.3892/mmr.2021.12392 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guozhong Zhao · 1 shared paper, 2021 · strength 0.12
- Paper miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1. DOI 10.3892/mmr.2021.12392 ↗
Weijie Yao · 1 shared paper, 2021 · strength 0.12
- Paper miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1. DOI 10.3892/mmr.2021.12392 ↗
Zuozheng Wang · 1 shared paper, 2021 · strength 0.12
- Paper miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1. DOI 10.3892/mmr.2021.12392 ↗
Yongfeng Hui · 1 shared paper, 2021 · strength 0.12
- Paper miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1. DOI 10.3892/mmr.2021.12392 ↗
Bendong Chen · 1 shared paper, 2021 · strength 0.12
- Paper miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1. DOI 10.3892/mmr.2021.12392 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.